Related Experiment Video

Updated: Aug 19, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Burkitt lymphoma and Williams syndrome: a model for children with a multisystem disorder and malignancy

Courtney D Thornburg1, Diane Roulston, Valerie P Castle

  • 1Department of Pediatrics/Division of Hematology/Oncology, University of Michigan Medical Center, Ann Arbor, Michigan, USA. cthorn@med.umich.edu

Journal of Pediatric Hematology/Oncology
|February 11, 2005
PubMed

Insights

Williams syndrome, a genetic disorder, is not typically linked to cancer. This case highlights challenges in treating Burkitt lymphoma in a child with Williams syndrome, emphasizing the need for tailored medical care.

Area of Science:

  • Genetics
  • Pediatric Oncology
  • Rare Diseases

Background:

  • Williams syndrome is a rare genetic disorder characterized by a contiguous gene deletion.
  • It is not generally associated with an increased risk of malignancy.
  • Managing cancer in children with Williams syndrome presents unique challenges due to multisystem involvement.

Observation:

  • A case report details a child diagnosed with Williams syndrome and Burkitt lymphoma, a specific type of non-Hodgkin lymphoma.
  • The lymphoma exhibited a characteristic chromosomal translocation, t(8;14).

Findings:

  • The treatment of this child incorporated the 2001 American Academy of Pediatrics health care guidelines for Williams syndrome.
  • The presence of Williams syndrome complicated the management of the Burkitt lymphoma due to the patient's underlying medical conditions.

Implications:

  • This case underscores the importance of adapting existing cancer treatment protocols for patients with complex genetic syndromes.
  • It suggests that disease-specific guidelines should be considered for children with multisystem disorders, such as Down syndrome, undergoing cancer treatment.
  • Further research may be needed to develop specialized guidelines for managing malignancies in children with rare genetic conditions like Williams syndrome.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...